Drug Type Interleukins |
Synonyms- |
Target |
Mechanism IL-2R agonists(Interleukin-2 receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingClinical |
First Approval Date- |
Regulation- |
Not Applicable | 190 | Low-dose recombination human IL-2 | qtrnlkjnzx(lurgduukhm) = The ratio of Th17/Treg cells decreased rapidly in one week but increased to a higher level after one month vmkjvuamna (xlxkfqquwx ) View more | Positive | 13 Jun 2018 | ||
Standard therapy | |||||||
Not Applicable | 5 | dgmeoabbxw(jqhcjzmwmo) = qkdudknrui glinpzpegi (lfaqxqcevf ) | Positive | 04 Nov 2015 | |||
dgmeoabbxw(jqhcjzmwmo) = rpfxzeiepz glinpzpegi (lfaqxqcevf ) |